BackMereo Biopharma Group Plc Overview

Mereo Biopharma Group Plc Total Liabilities

Latest total liabilities for MREO: $6.1M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$6.06M
↓ 28.29% YoYΔ $-2.39M vs prior year quarter

Peer trimmed avg / median

Loading

Mereo Biopharma Group Plc Total Liabilities History

Loading

Mereo Biopharma Group Plc vs. peers: Total Liabilities Comparison

Loading

Mereo Biopharma Group Plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Mereo Biopharma Group Plc (MREO) FAQ

Mereo Biopharma Group Plc (MREO) currently reports a total liabilities of $6.1M as of June 2026. That compares with $8.5M in the prior-year period — down 28.3% year over year. Use the charts on this page to explore Mereo Biopharma Group Plc's total liabilities history and peer comparisons.

Mereo Biopharma Group Plc's total liabilities decreased from $8.5M to $6.1M — a 28.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mereo Biopharma Group Plc reported $6.1M in total liabilities as of June 2026. That compares with $8.5M in the prior-year period — down 28.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $6.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mereo Biopharma Group Plc, and consider following MREO for alerts when major investors trade the stock.

Mereo Biopharma Group Plc is classified in the Healthcare sector. On total liabilities, it currently shows $6.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MREO with unrelated industries.